title: Evaluation of clinical pathology data: correlating changes with other study data.
abstract: During the conduct of in vivo toxicology studies, in-life, clinical pathology, and anatomic pathology parameters are collected and interpreted. These sets of parameters are evaluated in an integrative manner to determine the overall toxicity of a test article. For clinical pathology parameters, the inherent variability and physiologic factors affecting each analyte must be understood prior to interpretation. Changes in clinical pathology parameters that are considered to be test article-related are then assessed with respect to changes in the concurrent data sets such as clinical signs and anatomic pathology to determine the underlying pathophysiology. In this article, examples of hemolysis and hepatotoxicity are used to demonstrate the relationships among the various parameters and data sets. Whereas there was tight correlation of all data sets in the example of hemolysis in rats, the examples of altered enzymes and other biomarkers indicating liver injury and dysfunction were more often discordant with other data sets.
authors.affiliation: Amgen Inc, Seattle, Washington, USA neverds@amgen.com.
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Everds
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis; D035843:Biomedical Research; D002624:Chemistry, Clinical / Q000379:methods; D005260:Female; D006405:Hematology / Q000379:methods; D006801:Humans; D008297:Male; D051379:Mice; D010338:Pathology, Clinical / Q000379:methods*; D051381:Rats; D018675:Toxicity Tests / Q000379:methods*
chemical_list: D015415:Biomarkers
keywords: biomarker; clinical chemistry; clinical pathology; data interpretation; hematology; hemolysis; hepatotoxicity; safety assessment.